These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1715576)

  • 1. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif.
    Zapp ML; Hope TJ; Parslow TG; Green MR
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7734-8. PubMed ID: 1715576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency.
    Malim MH; Cullen BR
    Cell; 1991 Apr; 65(2):241-8. PubMed ID: 2015625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS; Petrovic A; Jeong KS; Venkatesan S
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
    Daly TJ; Doten RC; Rusche JR; Auer M
    J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif.
    Hope TJ; Huang XJ; McDonald D; Parslow TG
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7787-91. PubMed ID: 2217212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA.
    Invernizzi CF; Xie B; Richard S; Wainberg MA
    Retrovirology; 2006 Dec; 3():93. PubMed ID: 17176473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the HIV-1 Rev protein and its target sequence, the Rev responsive element.
    Olsen HS; Beidas S; Dillon P; Rosen CA; Cochrane AW
    J Acquir Immune Defic Syndr (1988); 1991; 4(6):558-67. PubMed ID: 2023097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals.
    Truant R; Cullen BR
    Mol Cell Biol; 1999 Feb; 19(2):1210-7. PubMed ID: 9891055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution oligomerization of the rev protein of HIV-1: implications for function.
    Cole JL; Gehman JD; Shafer JA; Kuo LC
    Biochemistry; 1993 Nov; 32(44):11769-75. PubMed ID: 8218247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex.
    Böhnlein E; Berger J; Hauber J
    J Virol; 1991 Dec; 65(12):7051-5. PubMed ID: 1942257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of recombinant Rev protein of human immunodeficiency virus type 1.
    Nalin CM; Purcell RD; Antelman D; Mueller D; Tomchak L; Wegrzynski B; McCarney E; Toome V; Kramer R; Hsu MC
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7593-7. PubMed ID: 2217189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scanning mutagenesis of the arginine-rich region of the human immunodeficiency virus type 1 Rev trans activator.
    Hammerschmid M; Palmeri D; Ruhl M; Jaksche H; Weichselbraun I; Böhnlein E; Malim MH; Hauber J
    J Virol; 1994 Nov; 68(11):7329-35. PubMed ID: 7523698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional analysis of the human immunodeficiency virus type 2 Rev protein.
    Dillon PJ; Nelbock P; Perkins A; Rosen CA
    J Virol; 1991 Jan; 65(1):445-9. PubMed ID: 1985207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements.
    Bogerd HP; Huckaby GL; Ahmed YF; Hanly SM; Greene WC
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5704-8. PubMed ID: 1905815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive in vitro analysis of HIV-1 Rev multimerization.
    Brice PC; Kelley AC; Butler PJ
    Nucleic Acids Res; 1999 May; 27(10):2080-5. PubMed ID: 10219079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA.
    Cochrane AW; Chen CH; Rosen CA
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1198-202. PubMed ID: 2405396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells.
    Stauber RH; Afonina E; Gulnik S; Erickson J; Pavlakis GN
    Virology; 1998 Nov; 251(1):38-48. PubMed ID: 9813201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo.
    Bogerd H; Greene WC
    J Virol; 1993 May; 67(5):2496-502. PubMed ID: 8474155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of human prothymosin alpha to the leucine-motif/activation domains of HTLV-I Rex and HIV-1 Rev.
    Kubota S; Adachi Y; Copeland TD; Oroszlan S
    Eur J Biochem; 1995 Oct; 233(1):48-54. PubMed ID: 7588773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.